ROSSARICommodities

Rossari Biotech Limited

Specialty Chemicals · ISIN INE02A801020 · BSE 543213 · NSE EQ · FV ₹2
Last price
₹441
+0.67%today
What this company does

Rossari Biotech Limited operates in Specialty Chemicals, part of the Commodities sector. It booked ₹697 cr of revenue in its latest quarter (Q1 FY27) and kept 5.0% of sales as profit.

In the report:
56out of 100
Equitytale Health Score
Mixed

Healthier than 56% of companies in Commodities, on all six measures of filed financials. Each measure is ranked against the 43–173 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
oversold
RSI (14)
28

At close. Not part of the score.

Profitability & returns49

How much profit it earns on the money it employs

Balance sheet45

How much it owes, and whether earnings cover the interest

Cash quality22

Whether reported profit actually arrives as cash

Growth & consistency85

Whether sales and profit have grown, and how steadily

Valuation60

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Is this company doing well?
not investment advice
Strengths
Makes a profit
Sales up 28% vs last year
Promoters hold 68%
No promoter shares pledged
Watch-outs
! Thin 5.0% net margin
! Operating cash flow is negative

What if I invest in ROSSARI?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh

The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹441 +0.67%
latest close · 2026-09-17
1-year return
-66.7%
52-wk low ₹42852-wk high ₹1,619
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio17.4Average
LowAverageHigh
P/B ratio1.83Moderate
Below bookModerateHigh
EV / EBITDA8.3Average
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity10.5%Fair
WeakFairStrong ▸15%
Return on capital15.5%Strong
WeakFairStrong
Net margin5.0%Decent
ThinDecentStrong
EBITDA margin12.0%Decent
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.31Comfortable
LowModerateHigh ▸1
Interest cover5.3×Strong
RiskyOkayStrong ▸5×
Current ratio1.57Healthy
Tight ◂1HealthyAmple
More figures
Market cap
₹2,441 cr
Book value
₹241
EPS
₹6.34
latest quarter
Net debt
₹333 cr
owes more than its cash
Enterprise value
₹2,774 cr
EBITDA
₹335 cr
annualised
EBIT
₹233 cr
annualised
Operating margin
8.3%
Return on assets
6.1%
Earnings yield
5.75%
P/S
0.88
Sales / share
₹503.5
Tax rate
26.6%
Face value
₹2
Shares
5.5 cr
Working capital
₹446 cr
Current assets
₹1,236 cr
Current liabilities
₹790 cr
Delivery %
56.0%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the FY 2026 report & filings
not investment advice
Looks overpricedMedium confidence
Median of 2 models ₹342 vs market price ₹441 — price is 29% above it
Safety cushion-28.7%(target ≥ +20%)
Models span ₹186₹499, midpoint ₹342
Model ₹342
Price ₹441
Cheap sideExpensive side

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹697 cr
Other Income₹3 cr
Total Income₹700 cr
Cost of Materials₹515 cr
Purchases of Stock-in-Trade₹15 cr
Inventory Change (±)₹-39 cr
Employee Benefit Expense₹44 cr
Finance Costs₹11 cr
Depreciation & Amortisation₹26 cr
Other Expenses₹82 cr
Total Expenses₹653 cr
Profit before Tax₹47 cr
Tax Expense₹13 cr
Share of JV / Associates₹45.7 L
Net Profit₹35 cr
Net margin on total income5.0%
Where the money goes · Q1 FY27
% of total income
Materials + stock-in-trade₹491 cr70.0%
Employee benefit expense₹44 cr6.3%
Finance costs₹11 cr1.6%
Depreciation & amortisation₹26 cr3.7%
Other expenses₹82 cr11.7%
Tax expense₹13 cr1.8%
Profit for the period₹35 cr5.0%
Total income ₹700 cradds up to ₹100 ✓
Quarterly results · consolidated (₹ cr)
MetricQ3 FY26Q4 FY26Q1 FY27
Revenue582 cr685 cr697 cr
Total income582 cr704 cr700 cr
Expenses540 cr640 cr653 cr
Profit before tax42 cr64 cr47 cr
Tax10 cr18 cr13 cr
Net profit (owners' share)33 cr46 cr35 cr
Net margin (owners' share, on revenue)5.6%6.7%5.0%
EPS (₹)5.928.306.34
YoY (latest quarter): total income +28.5% · net profit +4.5%
Balance sheet & cash flow · as of Mar 2026
Low debt
Total assets
₹2,289 cr
Shareholder equity
₹1,333 cr
parent shareholders
Total debt
₹408 cr
Cash
₹75 cr
Cash flow · H1 FY26
Operating
₹-25 cr
Investing
₹-106 cr
Financing
₹122 cr
Peer comparison
Specialty Chemicals · by market value
CompanyPriceMarket capP/E
Pidilite Industries Limited₹1,552₹1.58 L cr45.3
Gujarat Fluorochemicals Limited₹4,472₹49,190 cr55.4
Navin Fluorine International Limited₹8,220₹42,169 cr43.3
Deepak Nitrite Limited₹1,605₹21,889 cr15.9
Aether Industries Limited₹1,623₹21,543 cr85.1
Atul Limited₹6,134₹18,057 cr18.4
Aarti Industries Limited₹477₹17,287 cr27.9
Fine Organic Industries Limited₹5,202₹15,949 cr28.9
BASF India Limited₹3,602₹15,591 cr11.2
Same industry · latest reported numbers · not a recommendation.
Corporate actions
Dividend yield
0.11%
trailing 12 months
Dividend / share (TTM)
₹0.5
Last dividend
₹0.5
ex 10 Jul 2026
ActionDetailEx-date
Dividend₹0.5 / share10 Jul 2026
Dividend₹0.5 / share20 Jun 2025
Dividend₹0.5 / share16 Aug 2024
Dividend₹0.5 / share24 May 2023
Dividend₹0.5 / share7 Jul 2022
Dividend₹0.5 / share8 Sep 2021
Who owns it · 2026-06-30
No pledge
Promoter
68.1%
FII / Foreign
2.0%
DII / Domestic
14.6%
Retail / others
15.2%
Promoter stake down 0.2% over the last 12 quarters.
Smart-money activity
Insider trades
BoughtYash Suni Chari · Promoter Group23.00 L · ₹142.0 cr28 Aug 25
SoldSunil Srinivasan Chari · Promoters88.00 L · ₹543.2 cr28 Aug 25
BoughtJyotishna Sunil Chari · Promoter Group15.00 L · ₹92.6 cr28 Aug 25
Bulk / block deals
BoughtBHUPESH KUMAR LODHA · NSE2.98 L @ ₹491.530 Apr 26
short · NSE828 Jan 26
BoughtPUBLIC SECTOR PENSION INVESTMENT BOARD · NSE1.67 L @ ₹1,249.519 Jul 21
Stake changes
SoldSBI Mutual Fund under its Various Schemes→ 2.97% · 1.57 L17 Apr 26
BoughtMrs. Jyotishna Sunil Chari · promoter→ 4.52% · 15.00 L28 Aug 25
SoldSunil Srinivasan Chari · promoter→ 13.17% · 88.00 L28 Aug 25
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 30 Jun 2025
See the official result
1
1. To receive, consider and adopt the Audited Standalone Financial Statement of the Company for the Financial Year ended 31st March, 2025 and the reports of the Board of Directors and Auditors thereon.
Backed by 100% of shareholders other than promotersneeded 50%
1.06 cr votes for, 2 against · 0% of mutual funds and other big investors said no
2
2 - To receive, consider and adopt the Audited Consolidated Financial Statement of the Company for the Financial Year ended 31st March, 2025 and the report of Auditors thereon
Backed by 100% of shareholders other than promotersneeded 50%
1.06 cr votes for, 2 against · 0% of mutual funds and other big investors said no
3
3 - To declare a Dividend of Re. 0.50 (25%) per Equity Share of the face value of Rs. 2/- each for the Financial Year ended 31st March, 2025.
Backed by 100% of shareholders other than promotersneeded 50%
1.06 cr votes for, 2 against · 0% of mutual funds and other big investors said no
4
4 - To appoint a director in place of Mr. Sunil Chari (DIN: 00149083), who is liable to retire by rotation and being eligible, offers himself for re-appointment.
Backed by 99% of shareholders other than promotersneeded 50%
1.06 cr votes for, 67,882 against · 1% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 28 named members
owning 68.2% between them · as of 2026-06-30
Edward Menezes29.10%
Sunil Srinivasan Chari13.16%
Chari Family Trust in the name of Sunil Srinivasan Chari and Jyotishna Sunil Chari9.23%
Rossari Biotech India Private Limited5.45%
Jyotishna Sunil Chari4.51%
Yash Sunil Chari4.45%
Anita Menezes1.81%
Mikhail Menezes0.24%
Business done with them
FY2026 · 5 of the group
The company paid ₹4 cr to companies in the promoter group last year — about 0.2% of its ₹2,396 cr revenue.
SUNIL SRINIVASAN CHARI
Other payments to them · Miscellaneous Transactions
also owns 13.16% of the company
₹2 cr
company paid
YASH SUNIL CHARI
Other payments to them · Miscellaneous Transactions
also owns 4.45% of the company
₹1 cr
company paid
YASHIKA CHARI
Other payments to them · Miscellaneous Transactions
₹68.6 L
company paid
ROSSARI BIOTECH (INDIA) PRIVATE LIMITED
Other payments to them · Dividend Paid
also owns 5.45% of the company
₹15.1 L
company paid
JYOTISHNA SUNIL CHARI
Other payments to them · Miscellaneous Transactions
also owns 4.51% of the company
₹5 L
company paid

The company also transacted with 5 other related parties — subsidiaries, joint ventures, directors and others — that we could not match by name to the promoter list above. Some may still be connected to the family; we only count the ones the filings let us match with certainty.

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.